Arthritis

Study results from N. Neeman and colleagues update understanding of arthritis

Published in Pharma Law Weekly, December 8th, 2009

According to a study from the United States, "A 46-year-old female patient with a 1-year history of rheumatoid arthritis was treated with methotrexate, 15 mg per week. Because of clinical improvement and patient preference, her rheumatologist changed her treatment to minocycline, and her methotrexate dose was gradually reduced over several months."

"As she was making these medication changes, the patient discovered that she was pregnant. The methotrexate was soon discontinued, but she was still taking it for at least the first 3 weeks of her pregnancy. The patient delivered a full-term female infant who did not appear to have any methotrexate-related birth defects,"...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Pharma Law Weekly

Source: Pharma Law Weekly (2009-12-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry